rizatriptan

(redirected from Maxalt)
Also found in: Medical.

riz·a·trip·tan

 (rĭz′ə-trĭp′tn)
n.
An oral drug of the triptan class, C15H19N5, used in its benzoate form to treat migraine headaches.

[riza- (shortening and alteration of triazole) + -triptan, triptan suffix; see triptan.]
Translations

rizatriptan

n rizatriptán m
References in periodicals archive ?
In addition, her family physician prescribed Maxalt (sublingual and oral) for treatment of headaches with a variable clinical response including limited relief or no effect.
This single-dose, crossover, comparative bioavailability study includes 26 healthy volunteers and is intended to evaluate and compare therelative bioavailability and to assess the bioequivalenceof RHB-103 and the reference drug, Maxalt lingua, marketed in Germany by MSD SHARP & DOHME GMBH.
Placebo pills mislabeled as the migraine drug Maxalt provided close to as much pain relief as Maxalt mislabeled as a placebo.
Maxalt comes in both an oral and orally disintegrating form, and is available as a generic drug.
Each subject received placebo three times and Maxalt three times, each labeled once as "placebo," once as "Maxalt," and once as "Maxalt or placebo.
Such a move holds the promise of giving consumers access to chronic-condition drugs such as Avapro, Diovan and Atacand for hypertension; Lescol and Tricor for hyperlipidemia; Maxalt and Zomig for migraine; and Singulair and Xopenex for asthma.
A separate study compared the safety of telcagepant with an older migraine drug, Maxalt, that's sold by Merck.
For example, the popular "triptan" drugs, including Relpax, Imitrex and Maxalt, may no longer be safe to take if you have since developed high blood pressure, poorly controlled diabetes or elevated blood cholesterol.
Maxalt is an analgesic not recommended for children under age 18.
Currently approved "triptans" include Imitrex (sumatriptan), Zomig (zolmitriptan), and Maxalt (rizatriptan).
Its top products are well-known to anyone who has spent time waiting in line at a pharmacy: Propecia, Maxalt, Vioxx, Zocor and Vasotec, among others.
Maxalt is due to be officially launched by drug company Merck Sharp and Dohme during Migraine Awareness Week.